Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology
Go back to Sunshine Biopharma Announces Issuance of U.S. Patent 12,624,066 B2 Covering Novel Coronavirus Treatment Technology| Sunshine Biopharma, Inc. (NASDAQ: SBFM) | Delayed: 2.05 -0.08 (3.76%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.13 | 52 Week High | $0.04 | |||
| Open | $2.06 | 52 Week Low | $0.00 | |||
| Day High | $2.09 | P/E | N/A | |||
| Day Low | $2.03 | EPS | $0.00 | |||
| Volume | 36,715 | |||||
